Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-25EEG and Behavioral Correlates of Temporal Prediction in the Tactile Modality in Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-03-24Monotherapy of an NMDA Enhancer for Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-03-24Combination of NMDA-enhancing and Anti-inflammatory Treatments for Ultra-resistant Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-03-24Dual Modulation of Sigma-1 and NMDA Receptors in the Treatment of Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-03-24Effectiveness of Cue-based Intervention in Improving Prospective Memory by Enhancing Medication Adherence in Patients With Schizophrenia and Schizoaffective Disorder: A Randomized Controlled Trial
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-20A Phase 2a, Randomized, Participant- and Investigator- Blinded, Parallel-group, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With DSM-5 Schizophrenia (STAR-1)
-
CLINICAL_TRIALS study record update · 2026-03-20An Open-label, Multicenter Study to Determine the Pharmacokinetics, Safety, and Tolerability of AX251 Long-Acting Injectable (LAI) Administered as a Single Dose in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-03-19Cromoglicte Adjunctive Therapy for Outpatients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-03-19Cerebellar Transcranial Magnetic Stimulation and Cognitive Control
-
CLINICAL_TRIALS study record update · 2026-03-19The Effectiveness of a Peer-led Psycho-education Group in Schizophrenia: A Multi-site Randomised Controlled Trial
-
CLINICAL_TRIALS study record update · 2026-03-18Biomarker Research on Ultra-High-Field MRI Combined With Visual Perception Assessment in the Diagnosis and Treatment Outcomes of Severe Mental Disorders
-
CLINICAL_TRIALS study record update · 2026-03-18iTEST: Introspective Accuracy as a Novel Target for Functioning in Psychotic Disorders
-
CLINICAL_TRIALS study record update · 2026-03-18ED to EPI: Using SMS (Text) Messaging to Improve the Transition From the Emergency Department to Early Psychosis Intervention for Young People With Psychosis
-
CLINICAL_TRIALS study record update · 2026-03-18Tolerability of MDMA in Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-03-18Cognitive Effects of Transcranial Direct Current Stimulation (tDCS) and Transcranial Random Noise Stimulation (tRNS) in Schizophrenia: A Random, Crossover Study
-
CLINICAL_TRIALS study record update · 2026-03-18Enhancing Evidence-Based Practice for Youth and Emerging Adults With Early Psychosis: Implementation and Evaluation in Diverse Service Settings
-
CLINICAL_TRIALS study record update · 2026-03-17Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients: A Randomized, Double-Blind, Placebo-Controlled Multicenter Clinical Study
-
CLINICAL_TRIALS study record update · 2026-03-17A Phase 3, Randomized, Two-part Study With a 5-week Double-blind Part (Randomized, Parallelgroup, Placebo-controlled) Followed by a 52-week Open-label Extension Part to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Patients With Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (DSM-5) Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-03-17Cerebellar Modulation of Cognition in Psychosis
-
CLINICAL_TRIALS study record update · 2026-03-17Supportive Psychotherapy As An Adjunct To Risperidone Improves Cognitive Function And Reduces High-Sensitivity C-Reactive Protein (Hs-CRP) In Schizophrenia: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2026-03-16Impact of Cannabis Consumption on Psychotic Symptoms and Reality Monitoring in Patients With Schizophrenia: a Real-life Study
-
CLINICAL_TRIALS study record update · 2026-03-12Type 2 Diabetes Prevention and Management for People With Serious Mental Illness: A Feasibility Study
-
CLINICAL_TRIALS study record update · 2026-03-11Promoting Adaptive Decision-Making in Schizophrenia Through Improved Evidence Integration: A Combined Neuroimaging and Experience Sampling Study
-
CLINICAL_TRIALS study record update · 2026-03-11Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2026-03-11An Open-label Extension Study to Assess the Long-term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia